| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1922751 | Parkinsonism & Related Disorders | 2006 | 7 Pages |
Abstract
[123I]meta-iodobenzylguanidine (MIBG) myocardial scintigraphy is a useful diagnostic tool to differentiate Parkinson's disease and dementia with Lewy bodies (Lewy body disease) from other related movement disorders, PARK2, and Alzheimer's disease. Postmortem study revealed that cardiac sympathetic denervation occurs in Lewy body disease and indicates the presence of Lewy pathology, which accounts for the decreased cardiac uptake of MIBG in Lewy body disease. Moreover, degeneration of cardiac sympathetic nerve precedes the neuronal loss in the sympathetic ganglia.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Satoshi Orimo, Takeshi Amino, Atsushi Takahashi, Tohru Kojo, Toshiki Uchihara, Fumiaki Mori, Koichi Wakabayashi, Hitoshi Takahashi,